ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 64 filers reported holding ADURO BIOTECH INC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,947,000 | +4.4% | 801,513 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $1,865,000 | -10.2% | 807,796 | +6.5% | 0.00% | 0.0% |
| Q1 2020 | $2,077,000 | +170.4% | 758,613 | +16.5% | 0.00% | – |
| Q4 2019 | $768,000 | -5.2% | 651,082 | -14.8% | 0.00% | – |
| Q3 2019 | $810,000 | -38.6% | 763,900 | -10.8% | 0.00% | -100.0% |
| Q2 2019 | $1,319,000 | -56.6% | 856,741 | +12.1% | 0.00% | 0.0% |
| Q1 2019 | $3,042,000 | +105.5% | 764,226 | +36.3% | 0.00% | 0.0% |
| Q4 2018 | $1,480,000 | -31.6% | 560,660 | +90.5% | 0.00% | 0.0% |
| Q3 2018 | $2,163,000 | +398.4% | 294,288 | +374.5% | 0.00% | – |
| Q2 2018 | $434,000 | +83.9% | 62,017 | +143.9% | 0.00% | – |
| Q1 2018 | $236,000 | +23.6% | 25,429 | 0.0% | 0.00% | – |
| Q4 2017 | $191,000 | – | 25,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $14,025,000 | 1.27% |
| Ikarian Capital, LLC | 3,638,000 | $9,968,000 | 0.75% |
| Rubric Capital Management LP | 871,100 | $2,387,000 | 0.38% |
| Burrage Capital Management LLC | 135,898 | $363,000 | 0.36% |
| Soleus Capital Management, L.P. | 81,200 | $222,000 | 0.26% |
| Artal Group S.A. | 1,000,000 | $2,740,000 | 0.12% |
| BOOTHBAY FUND MANAGEMENT, LLC | 497,857 | $1,364,000 | 0.11% |
| Alambic Investment Management, L.P. | 10,700 | $29,000 | 0.07% |
| LORD, ABBETT & CO. LLC | 1,688,490 | $4,627,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 530,952 | $1,455,000 | 0.02% |